737 related articles for article (PubMed ID: 9294650)
21. Alpha-tocopheryl succinate (alpha-TOS) modulates human prostate LNCaP xenograft growth and gene expression in BALB/c nude mice fed two levels of dietary soybean oil.
Basu A; Grossie B; Bennett M; Mills N; Imrhan V
Eur J Nutr; 2007 Feb; 46(1):34-43. PubMed ID: 17180484
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological inhibition of FGF receptor signaling inhibits LNCaP prostate tumor growth, promatrilysin, and PSA expression.
Udayakumar TS; Bair EL; Nagle RB; Bowden GT
Mol Carcinog; 2003 Oct; 38(2):70-7. PubMed ID: 14502646
[TBL] [Abstract][Full Text] [Related]
23. Invasiveness of hepatocellular carcinoma cell lines: contribution of membrane-type 1 matrix metalloproteinase.
Murakami K; Sakukawa R; Ikeda T; Matsuura T; Hasumura S; Nagamori S; Yamada Y; Saiki I
Neoplasia; 1999 Nov; 1(5):424-30. PubMed ID: 10933057
[TBL] [Abstract][Full Text] [Related]
24. Stimulation of human prostatic carcinoma tumor growth in athymic mice and control of migration in culture by extracellular matrix.
Passaniti A; Isaacs JT; Haney JA; Adler SW; Cujdik TJ; Long PV; Kleinman HK
Int J Cancer; 1992 May; 51(2):318-24. PubMed ID: 1568798
[TBL] [Abstract][Full Text] [Related]
25. Role of plasminogen activator and of 92-KDa type IV collagenase in glioblastoma invasion using an in vitro matrigel model.
Rao JS; Steck PA; Tofilon P; Boyd D; Ali-Osman F; Stetler-Stevenson WG; Liotta LA; Sawaya R
J Neurooncol; 1994; 18(2):129-38. PubMed ID: 7964975
[TBL] [Abstract][Full Text] [Related]
26. Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines.
Hudson MA; McReynolds LM
J Natl Cancer Inst; 1997 May; 89(10):709-17. PubMed ID: 9168186
[TBL] [Abstract][Full Text] [Related]
27. Prostate-specific antigen modulates the expression of genes involved in prostate tumor growth.
Bindukumar B; Schwartz SA; Nair MP; Aalinkeel R; Kawinski E; Chadha KC
Neoplasia; 2005 Mar; 7(3):241-52. PubMed ID: 15799824
[TBL] [Abstract][Full Text] [Related]
28. Plasminogen activators in human prostate cancer cell lines and tumors: correlation with the aggressive phenotype.
Gaylis FD; Keer HN; Wilson MJ; Kwaan HC; Sinha AA; Kozlowski JM
J Urol; 1989 Jul; 142(1):193-8. PubMed ID: 2659823
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo.
Liu XH; Kirschenbaum A; Yao S; Lee R; Holland JF; Levine AC
J Urol; 2000 Sep; 164(3 Pt 1):820-5. PubMed ID: 10953162
[TBL] [Abstract][Full Text] [Related]
30. The use of matrigel has no influence on tumor development or PET imaging in FaDu human head and neck cancer xenografts.
Fliedner FP; Hansen AE; Jørgensen JT; Kjær A
BMC Med Imaging; 2016 Jan; 16():5. PubMed ID: 26762341
[TBL] [Abstract][Full Text] [Related]
31. Detection of matrix metalloproteinases (MMP), tissue inhibitor of metalloproteinase-2, urokinase and plasminogen activator inhibitor-1 within matrigel and growth factor-reduced matrigel basement membrane.
Gillette KM; Forbes K; Sehgal I
Tumori; 2003; 89(4):421-5. PubMed ID: 14606648
[TBL] [Abstract][Full Text] [Related]
32. Transplantation of human prostatic carcinoma into nude mice in Matrigel.
Pretlow TG; Delmoro CM; Dilley GG; Spadafora CG; Pretlow TP
Cancer Res; 1991 Jul; 51(14):3814-7. PubMed ID: 2065335
[TBL] [Abstract][Full Text] [Related]
33. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.
Mazzieri R; Masiero L; Zanetta L; Monea S; Onisto M; Garbisa S; Mignatti P
EMBO J; 1997 May; 16(9):2319-32. PubMed ID: 9171346
[TBL] [Abstract][Full Text] [Related]
34. Real-Time GFP Intravital Imaging of the Differences in Cellular and Angiogenic Behavior of Subcutaneous and Orthotopic Nude-Mouse Models of Human PC-3 Prostate Cancer.
Zhang Y; Toneri M; Ma H; Yang Z; Bouvet M; Goto Y; Seki N; Hoffman RM
J Cell Biochem; 2016 Nov; 117(11):2546-51. PubMed ID: 27012365
[TBL] [Abstract][Full Text] [Related]
35. Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis.
Huang S; Pettaway CA; Uehara H; Bucana CD; Fidler IJ
Oncogene; 2001 Jul; 20(31):4188-97. PubMed ID: 11464285
[TBL] [Abstract][Full Text] [Related]
36. Role of interleukin 10 and transforming growth factor beta1 in the angiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined immunodeficiency mice.
Stearns ME; Garcia FU; Fudge K; Rhim J; Wang M
Clin Cancer Res; 1999 Mar; 5(3):711-20. PubMed ID: 10100726
[TBL] [Abstract][Full Text] [Related]
37. Enhanced tumor growth of both primary and established human and murine tumor cells in athymic mice after coinjection with Matrigel.
Fridman R; Kibbey MC; Royce LS; Zain M; Sweeney M; Jicha DL; Yannelli JR; Martin GR; Kleinman HK
J Natl Cancer Inst; 1991 Jun; 83(11):769-74. PubMed ID: 1789823
[TBL] [Abstract][Full Text] [Related]
38. Neonatal hypothyroidism alters the pattern of prostatic growth and differentiation, as well as plasminogen activator and metalloprotease expression, in the rat.
Wilson MJ; Kirby JD; Zhao Y; Sinha AA; Cooke PS
Biol Reprod; 1997 Feb; 56(2):475-82. PubMed ID: 9116149
[TBL] [Abstract][Full Text] [Related]
39. Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice.
Kim SJ; Uehara H; Karashima T; Mccarty M; Shih N; Fidler IJ
Neoplasia; 2001; 3(1):33-42. PubMed ID: 11326314
[TBL] [Abstract][Full Text] [Related]
40. Role of human cripto-1 in tumor angiogenesis.
Bianco C; Strizzi L; Ebert A; Chang C; Rehman A; Normanno N; Guedez L; Salloum R; Ginsburg E; Sun Y; Khan N; Hirota M; Wallace-Jones B; Wechselberger C; Vonderhaar BK; Tosato G; Stetler-Stevenson WG; Sanicola M; Salomon DS
J Natl Cancer Inst; 2005 Jan; 97(2):132-41. PubMed ID: 15657343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
